[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:narcolepsy-without-cataplexy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":59,"states":60},"Narcolepsy without Cataplexy",8,[7,15,22,29,35,41,47,53],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07598708","A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence",[11],"Phase 2\u002FPhase 3","RECRUITING","2026-08-26T02:17:26.640202Z","2026-06-04T01:30:07.902175Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07502443","A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2",[19],"Phase 3","2026-08-26T02:17:48.768272Z","2026-05-05T02:43:28.872771Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT06952699","A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)",[26],"Phase 2","2026-08-26T02:16:22.235886Z","2026-05-05T02:43:26.936550Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":33,"content_modified":34},"NCT07625280","A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH",[19],"2026-08-26T02:17:16.126291Z","2026-06-05T00:55:50.379478Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT07493265","A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy",[26],"2026-08-26T02:19:17.380174Z","2026-05-29T15:36:40.189609Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT07096674","A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia",[26],"2026-08-26T02:15:30.699880Z","2026-05-05T02:43:29.160061Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT06767683","A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia",[11],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:27.166225Z",{"nct_id":54,"title":55,"phases":56,"status":12,"updated_at":57,"content_modified":58},"NCT06752668","A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia",[26],"2026-08-26T02:19:25.538428Z","2026-05-05T02:43:27.063315Z",[],[61,65,68,71,74,77,80,83,87,91,95,98],{"state":62,"count":63,"slug":64},"California",7,"california",{"state":66,"count":63,"slug":67},"Florida","florida",{"state":69,"count":63,"slug":70},"Georgia","georgia",{"state":72,"count":63,"slug":73},"North Carolina","north-carolina",{"state":75,"count":63,"slug":76},"Ohio","ohio",{"state":78,"count":63,"slug":79},"South Carolina","south-carolina",{"state":81,"count":63,"slug":82},"Texas","texas",{"state":84,"count":85,"slug":86},"Michigan",6,"michigan",{"state":88,"count":89,"slug":90},"Alabama",5,"alabama",{"state":92,"count":93,"slug":94},"Colorado",4,"colorado",{"state":96,"count":93,"slug":97},"Pennsylvania","pennsylvania",{"state":99,"count":100,"slug":101},"Arizona",3,"arizona"]